BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7683256)

  • 21. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia.
    Baars JW; de Boer JP; Wagstaff J; Roem D; Eerenberg-Belmer AJ; Nauta J; Pinedo HM; Hack CE
    Br J Haematol; 1992 Oct; 82(2):295-301. PubMed ID: 1419810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolytic response to interferon-alpha in healthy human subjects.
    Corssmit EP; Levi M; Hack CE; ten Cate JW; Sauerwein HP; Romijn JA
    Thromb Haemost; 1996 Jan; 75(1):113-7. PubMed ID: 8713789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects.
    Suffredini AF; Harpel PC; Parrillo JE
    N Engl J Med; 1989 May; 320(18):1165-72. PubMed ID: 2496309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
    Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
    Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome.
    Suharti C; van Gorp EC; Setiati TE; Dolmans WM; Djokomoeljanto RJ; Hack CE; ten CH; van der Meer JW
    Thromb Haemost; 2002 Jan; 87(1):42-6. PubMed ID: 11858187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant activated protein C attenuates endothelial injury and inhibits procoagulant microparticles release in baboon heatstroke.
    Bouchama A; Kunzelmann C; Dehbi M; Kwaasi A; Eldali A; Zobairi F; Freyssinet JM; de Prost D
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1318-25. PubMed ID: 18451327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
    J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
    Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
    Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
    Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
    [No Abstract]   [Full Text] [Related]  

  • 34. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
    Voss R; Matthias FR; Borkowski G; Reitz D
    Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
    Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli.
    Creasey AA; Stevens P; Kenney J; Allison AC; Warren K; Catlett R; Hinshaw L; Taylor FB
    Circ Shock; 1991 Feb; 33(2):84-91. PubMed ID: 2049816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in coagulation and fibrinolysis during sepsis.
    Kidokoro A; Iba T; Fukunaga M; Yagi Y
    Shock; 1996 Mar; 5(3):223-8. PubMed ID: 8696988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.
    Levi M; van Der POLL T; ten CATE H; Kuipers B; Biemond BJ; Jansen HM; ten CATE JW
    Am J Respir Crit Care Med; 1998 Jul; 158(1):92-8. PubMed ID: 9655712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model.
    de Boer JP; Creasey AA; Chang A; Abbink JJ; Roem D; Eerenberg AJ; Hack CE; Taylor FB
    Infect Immun; 1993 Dec; 61(12):5035-43. PubMed ID: 7693593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.